keyboard_backspace Back

Post-COVID respiratory management

A review of the literature

The lecture duration is 39min.

0.75 CPD Points, 0.75 CEUs, 0.75 CME credits approval pending.
Accredited by CPDUK, CBRN and Provider Pending.

You can watch this lecture for free! For premium features, including a CPD/CME accredited certificate, to use time-coded note taking or get downloadable slides, you will need a fair price subscription.

Sign In or Sign Up For Free to access this lecture.
Toufic Ahmad Chaaban
Clinical Assistant Professor, Critical Care & Pulmonary Medicine, Lebanese American University
Lecture Summary

COVID19 survivors suffer from persistent respiratory symptoms and functional limitations after the acute infection. Longitudinal studies after SARS-CoV2 infection showed impairment in lung function exercise capacity and Lung imaging abnormalities. In this lecture, we review possible post covid pulmonary involvement with a focus on whether they develop fibrosis. We also review the latest evidence on the long term follow up. Possible treatment strategies are discussed including antifibrotic therapy, mesenchymal cell therapy, prolonged steroids therapy and pulmonary rehabilitation. We conclude with recommendations for pulmonary follow up and post covid clinic design.

NB.

There are some minor audio issues during the recording. A new recording is coming soon

Target Audience

Critical Care Doctors
Experienced or advanced Critical Care Nurses

Learning Objectives:

Upon completion of this activity, you should be able to:

  • Review the natural history of lung impairment in previous viral pandemics
  • Understand the spectrum of lung diseases after moderate to severe COVID 19
  • Review the latest evidence on the long-term outcomes after moderate to severe COVID19 infection
  • Understand the rationale and the lack of evidence on antifibrotic treatment
  • Know the importance of pulmonary follow-up and post covid clinics

None.